Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve “disease control”, and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient’s perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician’s perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.
Chronic rhinosinusitis with nasal polyps: a survey on routine management and evaluation of disease control in practice / De Corso, Eugenio; Ottaviano, Giancarlo; Pipolo, Carlotta; Cantone, Elena; Mattavelli, Davide; Alicandri-Ciufelli, Matteo; Lucidi, Daniela; Caminati, Marco; Senna, Gianenrico; Cavaliere, Carlo; Ghidini, Angelo; Gallo, Stefania; Macchi, Alberto; Torretta, Sara; Seccia, Veronica; Garzaro, Massimiliano; Luca Fadda, Gian; Trimarchi, Matteo; Pasquini, Ernesto; Pagella, Fabio; Rikki Canevari, Frank; Preti, Andrea; La Mantia, Ignazio; Galli, Jacopo. - In: JOURNAL OF PERSONALIZED MEDICINE. - ISSN 2075-4426. - 13:11(2023). [10.3390/jpm13111531]
Chronic rhinosinusitis with nasal polyps: a survey on routine management and evaluation of disease control in practice
Carlo Cavaliere;
2023
Abstract
Chronic rhinosinusitis with nasal polyps (CRSwNP) is a disease with a significant impact on quality of life. The overall goal of CRSwNP management, as with other chronic conditions, is to achieve “disease control”, and for that reason, a definition of control of disease is pivotal in deciding the best treatment strategy. Although many staging systems have already been developed to evaluate the disease, disease control is not yet to be standardized, and a specific tool that is consistently applied and accepted by all practitioners is still missing in daily clinical practice. To gain an overview of the implementation and limitations of existing guidelines and to shed light on real-life definitions of control and disease severity, we conducted a nationwide survey of otorhinolaryngologists routinely treating CRSwNP to identify unmet clinical needs in Italy. The results showed homogeneous responses regarding the knowledge contained in international guidelines while highlighting the difficulty of their implementation in day-to-day practice. Respondents called attention to the importance of clinical symptoms, giving more weight to the patient’s perspective. Among the symptoms to be considered, respondents emphasized nasal obstruction, followed by loss of sense of smell and rhinorrhea. Others also believe that the physician’s perspective should be considered, and the inclusion of endoscopy as a measure of control was warranted by many. The need for a specific tool that is able to unequivocally ascertain disease control is increasingly pivotal in this new era of biologics for treating CRSwNP.File | Dimensione | Formato | |
---|---|---|---|
De Corso_Chronic Rhinosinusitis_2023.pdf
accesso aperto
Tipologia:
Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza:
Creative commons
Dimensione
246.73 kB
Formato
Adobe PDF
|
246.73 kB | Adobe PDF |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.